Patents - stay tuned to the technology

Inventors list

Assignees list

Classification tree browser

Top 100 Inventors

Top 100 Assignees


23rd week of 2016 patent applcation highlights part 8
Patent application numberTitlePublished
20160158114Disposable Emesis Bag with Comfort Features2016-06-09
20160158115Color Cosmetic with High Coverage and Naturalness2016-06-09
20160158116WRINKLE REDUCING SKIN PATCH, PROCESS OF MANUFACTURE AND USEFUL ARTICLES THEREOF2016-06-09
20160158117LONG LASTING BREATH MINT2016-06-09
20160158118OIL/OIL EMULSIONS CONTAINING PARTICLES WITH A BREAKAGE OF CURVATURE, COMPOSITIONS COMPRISING THEM AND USE OF THE PARTICLES FOR STABILIZING O/O EMULSIONS2016-06-09
20160158119PERSONALIZING SUBSTANCE FOR APPLICATION TO THE SKIN OR ADDITION TO TATTOO INK AND METHODS OF PREPARATION THEREOF2016-06-09
20160158120PERSONALIZING SUBSTANCE FOR APPLICATION TO THE SKIN OR ADDITION TO TATTOO INK AND METHODS OF PREPARATION THEREOF2016-06-09
20160158121POLYUREA CAPSULE COMPOSITIONS2016-06-09
20160158122Microbicidal Personal Care Compositions Comprising Metal Ions2016-06-09
20160158123KIT FOR WHITENING A BODY SURFACE OF A USER, RELATED METHOD AND PROCESS2016-06-09
20160158124Beauty Care Product2016-06-09
20160158125PRODUCTS FOR OXIDATIVELY CHANGING THE COLOR OF KERATIN FIBERS, IN A DISPENSER2016-06-09
20160158126BLEACHING AGENT CONTAINING FATTY ALCOHOLS2016-06-09
20160158127SKIN-CARE OIL2016-06-09
20160158128COMPOSITION FOR HAIR FRIZZ REDUCTION2016-06-09
20160158129PRODUCTS FOR OXIDATIVE COLOUR CHANGE OF KERATINOUS FIBRES IN A DISPENSER2016-06-09
20160158130HAIR DYE COMPOSITION2016-06-09
20160158131Compositions and Methods for Stimulating Collagen Synthesis in the Skin2016-06-09
20160158132Stabilization of Cosmetic Compositions2016-06-09
20160158133PRIMECOAT COMPOSITIONS FOR PROTEINACEOUS SUBSTRATES AND METHODS OF PRIMING PROTEINACEOUS SUBSTRATES THEREWITH2016-06-09
20160158134Stable Vitamin C System2016-06-09
20160158135COMPOSITION FOR HAIR FRIZZ REDUCTION2016-06-09
20160158136COMPOSITION FOR REDUCTION OF TRPA1 AND TRPV1 SENSATIONS2016-06-09
20160158137HAIR TREATMENT SYSTEMS AND METHODS USING PEPTIDES AND OTHER COMPOSITIONS2016-06-09
20160158138KERATIN-BASED HAIR STRAIGHTENING FORMULATIONS, METHODS AND SYSTEMS2016-06-09
20160158139Compositions Comprising A Sirt6 Activator And A DNA Repair Enzyme2016-06-09
20160158140CROSS-LINKED HYALURONIC ACID, PROCESS FOR THE PREPARATION THEREOF AND USE THEREOF IN THE AESTHETIC FIELD2016-06-09
20160158141FOAMING BLEACH-BLONDING COMPOSITIONS2016-06-09
20160158142BLEACHING AGENT CONTAINING POLYMERS2016-06-09
20160158143COSMETIC COMPOSITIONS2016-06-09
20160158144COSMETIC COMPOSITIONS2016-06-09
20160158145Container2016-06-09
20160158146OCULAR THERAPEUTIC AGENT DELIVERY DEVICES AND METHODS FOR MAKING AND USING SUCH DEVICES2016-06-09
20160158147COMPOSITION AND METHOD FOR ORALLY ADMINISTERING ONE OR MORE ACTIVE AGENTS TO A PET2016-06-09
20160158148METHOD FOR TREATING A PERIODONTAL DISEASE2016-06-09
20160158149Inhalable Pharmaceutical Compositions and the Inhaler Devices Containing Them2016-06-09
20160158150Manufacture of Pharmaceutical Compositions2016-06-09
20160158151ON DEMAND VESICLE FORMATION FROM VESICLE PRECURSORS SUITABLE FOR LONG-TERM STORAGE2016-06-09
20160158152PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF DIMINUTION OF BONE TISSUE2016-06-09
20160158153MULTICOMPARTMENTAL LIPID NANOPARTICLES2016-06-09
20160158154PROTEIN VESICLES AND METHODS OF MAKING AND USING THEREOF2016-06-09
20160158155MAGNETIC NANOPARTICLES USEFUL FOR MAGNETIC SENSOR DETECTION ESPECIALLY IN BIOSENSOR APPLICATIONS2016-06-09
20160158156HEAT-STABLE DRY POWDER PHARMACEUTICAL COMPOSITIONS AND METHODS2016-06-09
20160158157ANTI-TUBERCULOSIS STABLE PHARMACEUTICAL COMPOSITION IN A FORM OF A COATED TABLET COMPRISING GRANULES OF ISONIAZID AND GRANULES OF RIFAPENTINE AND ITS PROCESS OF PREPARATION2016-06-09
20160158158Encased Tamper Resistant Controlled Release Dosage Forms2016-06-09
20160158159PHARMACEUTICAL COMPOSITIONS AND RELATED METHODS OF DELIVERY2016-06-09
20160158160NANOFIBROUS MATERIALS AS DRUG, PROTEIN, OR GENETIC RELEASE VEHICLES2016-06-09
20160158161PLASTER CONTAINING FENTANYL2016-06-09
20160158162PHARMACEUTICAL COMPOSITIONS COMPRISING MONOTERPENES2016-06-09
20160158163Method For Treating Gefitinib-Resistant Non-Small-Cell Lung Cancer2016-06-09
20160158164PTEROSTILBENE (PTER) FOR USE IN THE PREVENTION AND/OR TREATMENT OF SKIN DISEASES, DAMAGES OR INJURIES2016-06-09
20160158165Combination Therapies for the Treatment of Alzheimer's Disease and Related Disorders2016-06-09
20160158166METHODS OF REDUCING BRAIN CELL APOPTOSIS2016-06-09
20160158167THERAPEUTIC AGENTS FOR USE IN THE PROPYLAXIS AND/OR TREATMENT OF HYPERKINETIC MOVEMENT DISORDERS2016-06-09
20160158168METHODS FOR THE BIOSYNTHESIS OF TAURINE OR HYPOTAURINE IN CELLS2016-06-09
20160158169Antimicrobial Compositions with Cysteamine2016-06-09
20160158170Delayed Release Cysteamine Bead Formulation, And Methods Of Making And Using Same2016-06-09
20160158171METHOD FOR TREATING INFLAMMATION AND PAIN2016-06-09
20160158172PYRAZOLOPYRIDAZINES AND METHODS FOR TREATING RETINAL-DEGENERATIVE DISEASES AND HEARING LOSS ASSOCIATED WITH USHER SYNDROME2016-06-09
20160158173METHODS FOR TREATING BRAIN INJURY2016-06-09
20160158174Enteric-Coated Functional Food Ingredients And Methods For Making The Enteric-Coated Functional Food Ingredients2016-06-09
20160158175CITRATE RESORPTION OF BONE AS A TREATMENT FOR SPINAL STENOSIS2016-06-09
20160158177NUTRITIONAL COMPOSITION FOR IMPROVING BRAIN FUNCTION IN PHENYLKETONURIA2016-06-09
20160158178DOSAGE FORMS AND THERAPEUTIC USES L-4-CHLOROKYNURENINE2016-06-09
20160158179NANOEMULSION THERAPEUTIC COMPOSITIONS AND METHODS OF USING THE SAME2016-06-09
20160158180Use of Derivatives of Polyunsaturated Fatty Acids as Medicaments2016-06-09
20160158181Use of Derivatives of Polyunsaturated Fatty Acids as Medicaments2016-06-09
20160158182OPHTHALMIC COMPOSITIONS CONTAINING A NITRIC OXIDE DONOR2016-06-09
20160158183COMPOSITIONS AND METHODS COMPRISING MEDIUM CHAIN TRIGLYCERIDES FOR TREATMENT OF EPILEPSY2016-06-09
20160158184SELF-EMULSIFYING COMPOSITION OF OMEGA3 FATTY ACID2016-06-09
20160158185SARMS AND METHOD OF USE THEREOF2016-06-09
20160158186USE OF DIANHYDROGALACTITOL AND ANALOGS AND DERIVATIVES THEREOF TO TREAT RECURRENT MALIGNANT GLIOMA OR PROGRESSIVE SECONDARY BRAIN TUMOR2016-06-09
20160158187TIGLIEN-3-ONE DERIVATIVES2016-06-09
20160158188NOVEL USE FOR PAI-1 INHIBITOR2016-06-09
20160158189SENSITIZATION OF CANCER CELLS TO APOPTOSIS INDUCTION BY FLAVAGLINES AND 5-HYDROXY-FLAVONES2016-06-09
20160158190Methods and Compositions for Inhibition of ATR and FANCD2 Activation2016-06-09
20160158191Combination Therapies for the Treatment of Alzheimer's Disease and Related Disorders2016-06-09
20160158192Combination Therapies for the Treatment of Alzheimer's Disease and Related Disorders2016-06-09
20160158193ADJUVANTS IN ANTI-CANCER CHEMOTHERAPY2016-06-09
20160158194Methods and Treatments for the Learning and Memory Deficits Associated with Noonan Syndrome2016-06-09
20160158195REDUCTION OF EPILEPTIC SEIZURES2016-06-09
20160158196A MODIFIED-RELEASE ORAL PHARMACEUTICAL FORMULATION CONTAINING GLICLAZIDE2016-06-09
20160158197Novel 1-Aryl-3-Azabicyclo[3.1.0]Hexanes: Preparation And Use To Treat Neuropsychiatric Disorders2016-06-09
20160158198COMPOSITIONS AND METHODS FOR AMELIORATING CACHEXIA2016-06-09
20160158199METHOD OF ACTIVATING REGULATORY T CELLS WITH ALPHA-2B ADRENERGIC RECEPTOR AGONISTS2016-06-09
20160158200Combinations of Hepatitis C Virus Inhibitors2016-06-09
20160158201CHEMICAL COMPOUNDS2016-06-09
20160158202Low Dose Pharmaceutical Composition2016-06-09
20160158203METHODS OF TREATMENT WITH BIOAVAILABLE COMPOSITIONS OF METAXALONE COMPRISING NONVOLATILE LIQUIDS2016-06-09
20160158204PHARMACOLOGICAL STIMULATION TO FACILITATE AND RESTORE STANDING AND WALKING FUNCTIONS IN SPINAL CORD MOTOR DISORDERS2016-06-09
20160158205COMPOSITIONS AND METHODS FOR TREATING CONDITIONS RELATED TO ELEVATED LEVELS OF EOSINOPHILS AND/OR BASOPHILS2016-06-09
20160158206Reversing Intestinal Inflammation by Inhibiting Retinoic Acid Metabolism2016-06-09
20160158207THERAPEUTIC COMPOUNDS AND USES THEREOF2016-06-09
20160158208METHODS OF USE OF CYCLOPAMINE ANALOGS2016-06-09
20160158209Compounds for Treatment of Alzheimer's Disease2016-06-09
20160158210CORNEAL ENDOTHELIUM ECM THERAPEUTIC MEDICAMENTS2016-06-09
20160158211Dosage and Use of an A2A Antagonist2016-06-09
20160158212EXTENDED RELEASE AQUEOUS SUSPENSION OF METHYLPHENIDATE OR SALTS THEREOF2016-06-09
20160158213USE OF FLECAINIDE AS AN ANTI-CONNEXIN AGENT AND METHOD FOR POTENTIATING THE EFFECTS OF A PSYCHOTROPIC DRUG2016-06-09
20160158214HEPATITIS B ANTIVIRAL AGENTS2016-06-09
Website © 2021 Advameg, Inc.